Emergence of carbapenem resistant gram-negative pathogens with high rate of colistin resistance in Egypt: A cross sectional study to assess resistance trends during the COVID-19 pandemic

Emergence of carbapenem resistant gram-negative pathogens with high rate of colistin resistance in Egypt: A cross sectional study to assess resistance trends during the COVID-19 pandemic

The current study investigated the temporal phenotypic and genotypic antimicrobial resistance (AMR) trends among multi-drug resistant and carbapenem-resistant Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa recovered from Egyptian clinical settings between 2020 and 2021. B...

Full description

Bibliographic Details
Main Authors:	Fatma A. Afify, Ahmed H. Shata, Nirmeen Aboelnaga, Dina Osama, Salma W. Elsayed, Nehal A. Saif, Shaimaa F. Mouftah, Sherine M. Shawky, Ahmed A. Mohamed, Omar Loay, Mohamed Elhadidy
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Journal of Genetic Engineering and Biotechnology
Subjects:	Gram negative bacteria Multidrug resistance Colistin resistance Carbapenem resistance Class 1 integron
Online Access:	http://www.sciencedirect.com/science/article/pii/S1687157X2300001X

Similar Items

Carbapenem and colistin resistance in children with Enterobacteriaceae infections
by: Zeliha Haytoğlu, et al.
Published: (2020-10-01)

Effectiveness of Colistin in carbapenem resistant Acinetobacter baumannii – A systematic review
by: Feroz Ahmed, et al.
Published: (2023-09-01)

Association of Carbapenem and Colistin Resistance in Pathogenic Gram Negative Bacteria
by: Reham Osama, et al.
Published: (2019-06-01)

Colistin and carbapenem resistance among Pseudomonas and Acinetobacter clinical isolates in Menoufia University Hospitals
by: Amal Makled, et al.
Published: (2024-02-01)

Characterization of resistance mechanisms of Enterobacter cloacae Complex co-resistant to carbapenem and colistin
by: Shixing Liu, et al.
Published: (2021-07-01)

Effect of colistin-tigecycline combination on colistin-resistant and carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii
by: Suyeon Park, et al.
Published: (2025-02-01)

Outcome of carbapenem or colistin resistant Klebsiella pneumoniae bacteremia in the intensive care unit
by: Cihan Semet, et al.
Published: (2024-10-01)

Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
by: Po-Han Huang, et al.
Published: (2022-06-01)

Effectiveness of ceftazidime–avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia
by: Hakeam A. Hakeam, et al.
Published: (2021-08-01)

Colistin use in a carbapenem-resistant Enterobacterales outbreak at a South African neonatal unit
by: Ilhaam Abrahams, et al.
Published: (2023-01-01)

Colistin broth disk elution for the detection of Colistin resistance among Carbapenem-resistant Klebsiella pneumoniae
by: Phu Thien Truong, et al.
Published: (2025-01-01)

Molecular epidemiology and mechanisms of carbapenem and colistin resistance in Klebsiella and other Enterobacterales from treated wastewater in Croatia
by: Ana Puljko, et al.
Published: (2024-03-01)

Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe
by: Ivana Goic-Barisic, et al.
Published: (2023-06-01)

Increasing trends of colistin resistance in patients at high-risk of carbapenem-resistant Enterobacteriaceae
by: Hadir A. El-Mahallawy, et al.
Published: (2022-12-01)

In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2021-07-01)

Emergence of colistin-heteroresistant and carbapenem-resistant hypervirulent Klebsiella pneumoniae
by: Tao Wang, et al.
Published: (2023-12-01)

Genomic characterization of carbapenem and colistin-resistant Klebsiella pneumoniae isolates from humans and dogs
by: Ruttana Pachanon, et al.
Published: (2024-05-01)

In vivo Emergence of Colistin and Tigecycline Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae During Antibiotics Treatment
by: Jiawei Chen, et al.
Published: (2021-09-01)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
by: Shi H, et al.
Published: (2019-12-01)

Colistin-resistance gene mcr in clinical carbapenem-resistant Enterobacteriaceae strains in China, 2014–2019
by: Hong Huang, et al.
Published: (2020-01-01)

Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii
by: Hadas Kon, et al.
Published: (2023-06-01)

Occurrence of Extended Spectrum Cephalosporin-, Carbapenem- and Colistin-Resistant Gram-Negative Bacteria in Fresh Vegetables, an Increasing Human Health Concern in Algeria
by: Widad Chelaghma, et al.
Published: (2022-07-01)

Tracking clonal and plasmid transmission in colistin- and carbapenem-resistant Klebsiella pneumoniae
by: Ifeoluwa Akintayo, et al.
Published: (2025-02-01)

Genomic dynamics of high-risk carbapenem-resistant Klebsiella pneumoniae clones carrying hypervirulence determinants in Egyptian clinical settings
by: Nehal Adel Abdelsalam, et al.
Published: (2024-10-01)

Pairing Colicins B and E5 with Bdellovibrio bacteriovorus To Eradicate Carbapenem- and Colistin-Resistant Strains of Escherichia coli
by: Sumudu Upatissa, et al.
Published: (2023-06-01)

Regional insights on the prevalence and antimicrobial susceptibility pattern of carbapenem and colistin-resistant gram-negative bacteria: an observational cross-sectional study from Karachi, Pakistan
by: Nazia Khursheed, et al.
Published: (2025-02-01)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
by: Rujipas Sirijatuphat, et al.
Published: (2022-11-01)

Clinical and microbiological analyses of colistin-resistant strains among carbapenem-resistant Enterobacter cloacae complex clinical isolates
by: Jinyoung Yang, et al.
Published: (2025-02-01)

Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to Carbapenem-Resistant Enterobacterales: A Multicenter Cohort Study
by: Almangour TA, et al.
Published: (2022-01-01)

Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases
by: Yuanbing Wu, et al.
Published: (2024-01-01)

Carbapenem- and colistin-resistant Enterobacterales in intensive care unit patients in Mediterranean countries, 2019
by: Sandra Dos Santos, et al.
Published: (2024-04-01)

Colistin and Carbapenem-Resistant <i>Acinetobacter baumannii</i> Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
by: Nalumon Thadtapong, et al.
Published: (2021-08-01)

Phenotypic and genotypic characterization of extended spectrum beta-lactamase producing E. coli harboring carbapenem and colistin resistant genes from poultry farms in Egypt
by: Reem I. Ali, et al.
Published: (2024-01-01)

Assessing Colistin Resistance by Phenotypic and Molecular Methods in Carbapenem-resistant Enterobacterales in a Tertiary Care Hospital in Pakistan
by: Furqan W, et al.
Published: (2022-10-01)

Efficacies of Colistin–Carbapenem versus Colistin–Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study
by: Sheng-Huei Wang, et al.
Published: (2021-09-01)

Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant Enterobacterales in Egypt: A Cross-Sectional Study
by: Shrief R, et al.
Published: (2022-10-01)

Molecular characteristics of carbapenem-resistant Acinetobacter spp. from clinical infection samples and fecal survey samples in Southern China
by: Si Li, et al.
Published: (2019-10-01)

Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study
by: Davide Fiore Bavaro, et al.
Published: (2023-09-01)

Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil?
by: Flavia Rossi, et al.

Comparison of cefiderocol and colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review with meta-analysis and trial sequential analysis
by: Yangyang Zhan, et al.
Published: (2024-09-01)